Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors

M. Kožíšek, V. Navrátil, K. Rojíková, J. Pokorná, C. Berenguer Albiñana, P. Pachl, J. Zemanová, A. Machara, P. Šácha, J. Hudlický, I. Císařová, P. Řezáčová, J. Konvalinka,

. 2018 ; 475 (23) : 3847-3860. [pub] 20181210

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19028106

Influenza neuraminidase is responsible for the escape of new viral particles from the infected cell surface. Several neuraminidase inhibitors are used clinically to treat patients or stockpiled for emergencies. However, the increasing development of viral resistance against approved inhibitors has underscored the need for the development of new antivirals effective against resistant influenza strains. A facile, sensitive, and inexpensive screening method would help achieve this goal. Recently, we described a multiwell plate-based DNA-linked inhibitor antibody assay (DIANA). This highly sensitive method can quantify femtomolar concentrations of enzymes. DIANA also has been applied to high-throughput enzyme inhibitor screening, allowing the evaluation of inhibition constants from a single inhibitor concentration. Here, we report the design, synthesis, and structural characterization of a tamiphosphor derivative linked to a reporter DNA oligonucleotide for the development of a DIANA-type assay to screen potential influenza neuraminidase inhibitors. The neuraminidase is first captured by an immobilized antibody, and the test compound competes for binding to the enzyme with the oligo-linked detection probe, which is then quantified by qPCR. We validated this novel assay by comparing it with the standard fluorometric assay and demonstrated its usefulness for sensitive neuraminidase detection as well as high-throughput screening of potential new neuraminidase inhibitors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028106
003      
CZ-PrNML
005      
20190816120323.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1042/BCJ20180764 $2 doi
035    __
$a (PubMed)30404922
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kožíšek, Milan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic milan.kozisek@uochb.cas.cz konval@uochb.cas.cz.
245    10
$a DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors / $c M. Kožíšek, V. Navrátil, K. Rojíková, J. Pokorná, C. Berenguer Albiñana, P. Pachl, J. Zemanová, A. Machara, P. Šácha, J. Hudlický, I. Císařová, P. Řezáčová, J. Konvalinka,
520    9_
$a Influenza neuraminidase is responsible for the escape of new viral particles from the infected cell surface. Several neuraminidase inhibitors are used clinically to treat patients or stockpiled for emergencies. However, the increasing development of viral resistance against approved inhibitors has underscored the need for the development of new antivirals effective against resistant influenza strains. A facile, sensitive, and inexpensive screening method would help achieve this goal. Recently, we described a multiwell plate-based DNA-linked inhibitor antibody assay (DIANA). This highly sensitive method can quantify femtomolar concentrations of enzymes. DIANA also has been applied to high-throughput enzyme inhibitor screening, allowing the evaluation of inhibition constants from a single inhibitor concentration. Here, we report the design, synthesis, and structural characterization of a tamiphosphor derivative linked to a reporter DNA oligonucleotide for the development of a DIANA-type assay to screen potential influenza neuraminidase inhibitors. The neuraminidase is first captured by an immobilized antibody, and the test compound competes for binding to the enzyme with the oligo-linked detection probe, which is then quantified by qPCR. We validated this novel assay by comparing it with the standard fluorometric assay and demonstrated its usefulness for sensitive neuraminidase detection as well as high-throughput screening of potential new neuraminidase inhibitors.
650    _2
$a antivirové látky $x chemie $x farmakologie $7 D000998
650    _2
$a DNA $x chemie $7 D004247
650    _2
$a preklinické hodnocení léčiv $x metody $7 D004353
650    _2
$a inhibitory enzymů $x chemie $x farmakologie $7 D004791
650    _2
$a lidé $7 D006801
650    _2
$a virus chřipky A $x účinky léků $x enzymologie $x fyziologie $7 D009980
650    _2
$a chřipka lidská $x farmakoterapie $x enzymologie $x virologie $7 D007251
650    _2
$a neuraminidasa $x antagonisté a inhibitory $x metabolismus $7 D009439
650    _2
$a oseltamivir $x analogy a deriváty $x chemie $7 D053139
650    _2
$a kyseliny fosforité $x chemie $7 D010757
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a virové proteiny $x antagonisté a inhibitory $x metabolismus $7 D014764
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Navrátil, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic.
700    1_
$a Rojíková, Kateřina $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic.
700    1_
$a Pokorná, Jana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic.
700    1_
$a Berenguer Albiñana, Carlos $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 12800 Prague 2, Czech Republic.
700    1_
$a Pachl, Petr $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic.
700    1_
$a Zemanová, Jitka $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic.
700    1_
$a Machara, Aleš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 12800 Prague 2, Czech Republic.
700    1_
$a Šácha, Pavel $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic.
700    1_
$a Hudlický, Jason $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 12800 Prague 2, Czech Republic.
700    1_
$a Císařová, Ivana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic. Department of Inorganic Chemistry, Faculty of Science, Charles University, Hlavova 8, 12843 Prague 2, Czech Republic.
700    1_
$a Řezáčová, Pavlína $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic. Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic, Vídeňská 1083, 14000 Prague 4, Czech Republic.
700    1_
$a Konvalinka, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Gilead Sciences and IOCB Research Center, Flemingovo n. 2, 16610 Prague 6, Czech Republic milan.kozisek@uochb.cas.cz konval@uochb.cas.cz. Department of Biochemistry, Faculty of Science, Charles University, Hlavova 8, 12800 Prague 2, Czech Republic.
773    0_
$w MED00009308 $t The Biochemical journal $x 1470-8728 $g Roč. 475, č. 23 (2018), s. 3847-3860
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30404922 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190816120553 $b ABA008
999    __
$a ok $b bmc $g 1433255 $s 1066566
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 475 $c 23 $d 3847-3860 $e 20181210 $i 1470-8728 $m Biochemical journal (London. 1984) $n Biochem J $x MED00009308
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Archiving options